Omrix Biopharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

Published : November 2010
No. of Pages : 40

Price:

Omrix Biopharmaceuticals, Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Omrix Biopharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Omrix Biopharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Omrix Biopharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Omrix Biopharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Omrix Biopharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Omrix Biopharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Omrix Biopharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Omrix Biopharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Omrix Biopharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Omrix Biopharmaceuticals, Inc. and identify potential opportunities in those areas.

Table of Contents 2
List of Tables 4
List of Figures 4
Omrix Biopharmaceuticals, Inc. Snapshot 5
Omrix Biopharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Omrix Biopharmaceuticals, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Omrix Biopharmaceuticals, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Omrix Biopharmaceuticals, Inc. – Pipeline Products Glance 10
Omrix Biopharmaceuticals, Inc. – Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Omrix Biopharmaceuticals, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Omrix Biopharmaceuticals, Inc.–Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Omrix Biopharmaceuticals, Inc. – Drug Profiles 13
HBIG 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Omr-IgG-am 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
WNIG 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
HT-VIG 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Omrix Biopharmaceuticals, Inc. – Pipeline Analysis 17
Omrix Biopharmaceuticals, Inc. – Pipeline Products by Therapeutic Class 17
Omrix Biopharmaceuticals, Inc. – Pipeline Products by Route of Administration 18
Omrix Biopharmaceuticals, Inc. – Pipeline Products by Molecule Type 19
Omrix Biopharmaceuticals, Inc. – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Omrix Biopharmaceuticals, Inc. - Key Manufacturing Facilities 21
Recent Developments 22
Sep 08, 2010: Octapharma Initiates Phase II/III Study Of Intravenous Immunoglobulin Preparation For Treatment Of Chronic Inflammatory Demyelinating Polyradiculoneuropathy 22
Financial Deals Landscape 23
Omrix Biopharmaceuticals, Inc., Deals Volume Summary, 2004 to YTD 2010 23
Omrix Biopharmaceuticals, Inc., Deals Summary By Region, 2004 to YTD 2010 24
Omrix Biopharmaceuticals, Inc., Deals Summary, 2004 to YTD 2010 25
Omrix Biopharmaceuticals, Inc. Detailed Deal Summary 26
Acquisition 26
Johnson & Johnson Completes Acquisition Of Omrix Biopharmaceuticals 26
Private Equity 29
Savient Pharmaceuticals Sells Its Stake In Omrix Biopharmaceuticals To Catalyst Investments 29
Equity Offering 31
Omrix Biopharmaceuticals Completes Public Offering Of $55 Million 31
Omrix Biopharmaceuticals Completes Initial Public Offering Of $39.53 Million 33
Omrix Biopharmaceuticals Completes Private Placement Of $5 Million 35
Omrix Biopharmaceuticals Signs An Agreement With NIAID 36
Omrix Biopharmaceuticals Enters Into An Agreement With FFF Enterprises 37
Omrix Biopharmaceuticals Enters Into Co-Marketing Agreement With American Red Cross Plasma Services 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 40
Contact Us 40
Disclaimer 40

Omrix Biopharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: